In Suenaga et al., they demonstrated that patients with colorectal cancer who possessed CCL5 rs2280789 G alleles had poorer outcomes with shortened PFS and OS rates, as well as poor tumor response compared to those with the AA variant. Here, CCL5 is linked to neoplasm.